Provided by Tiger Trade Technology Pte. Ltd.

ZHONGZHIPHARM

0.690
+0.0101.47%
Volume:298.00K
Turnover:203.98K
Market Cap:596.16M
PE:34.50
High:0.715
Open:0.665
Low:0.665
Close:0.680
52wk High:0.980
52wk Low:0.500
Shares:864.00M
HK Float Shares:863.60M
Volume Ratio:0.76
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.020
ROE:1.63%
ROA:0.38%
PB:0.46
PE(LYR):34.50
PS:0.31

Loading ...

Chinese Traditional Medicine Maker Tong Ren Tang Profit Falls on Weaker Demand

Reuters
·
Aug 28

China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices

Reuters
·
Aug 28

China's Kindstar Globalgene H1 Loss Narrows After Oncology Testing Expansion

Reuters
·
Aug 27

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Reuters
·
Aug 26

Zhongzhi Pharm Posts Interim Results with 3.79% Rise in Net Profit Attributable to Shareholders

Stock News
·
Aug 26

Zhongzhi Pharma FY26 H1 Profit Attributable to Owners Rises 3.8% to RMB 9.1 Million; Revenue Falls 10.3% to RMB 790 Million

Reuters
·
Aug 26

Zhongzhi Pharmaceutical Holdings H1 Net Income Attributable RMB 9.1 Million

THOMSON REUTERS
·
Aug 26

ZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend

Bulletin Express
·
Aug 14

Zhongzhi Pharmaceutical Schedules Board Meeting to Review Interim Results, Dividend Plan

Reuters
·
Aug 14

Zhongzhi Pharmaceutical Affirms Stable Share Base and Compliance with Public Float in May 2026

Bulletin Express
·
Jun 01

Zhongzhi Pharmaceutical held annual shareholder meeting, resolutions passed by vote

Reuters
·
May 13

Zhongzhi Pharm Maintains Stable Share Capital and Meets Public Float Requirement in April 2026

Bulletin Express
·
May 04

Zhongzhi Pharmaceutical Holdings' (HKG:3737) Weak Earnings May Only Reveal A Part Of The Whole Picture

Simply Wall St.
·
Apr 28

ZHONGZHIPHARM Publishes 2025 Annual Report, Issues AGM Notice for 13 May 2026

Bulletin Express
·
Apr 20

中智药业2025年业绩下滑 生产与零售两大板块调整加速

Bulletin Express
·
Apr 20

Zhongzhi Pharma Calls 13 May 2026 AGM; Seeks 10% Buy-back Mandate, 20% Issuance Capacity and Board Re-elections

Bulletin Express
·
Apr 20

Zhongzhi Pharmaceutical publishes 2025 annual report

Reuters
·
Apr 20

Zhongzhi Pharm Keeps Share Capital and Float Stable in March 2026

Bulletin Express
·
Apr 01

ZHONGZHIPHARM (03737) Reports 2025 Financial Results: Profit Attributable to Equity Holders Plummets 81.8% to 17.29 Million Yuan

Stock News
·
Mar 26

Zhongzhi Pharmaceutical FY2025 profit attributable to equity holders drops 81.8% to RMB17 million; revenue falls 21.6% to RMB1.7 billion

Reuters
·
Mar 26